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ABSTRACT
Pokeweed antiviral protein (PAP) is a ribosome
inactivating protein recognized primarily for its
ability to depurinate the sarcin/ricin loop of the
large rRNA. Studies have demonstrated that PAP
also depurinates other RNA templates, such as
Human immunodeficiency virus-1 RNA and Brome
mosaic virus RNAs. However, the mechanism by
which PAP accesses viral RNAs is not known.
Considering that PAP was shown recently to bind
the m
7G of the cap structure, we speculated that
PAP may interact with other factors involved in trans-
lation initiation. By far western analysis, we show
that PAP binds specifically to eIF4G and eIFiso4G
of wheat germ and analysis with truncation mutants
of eIFiso4G indicates that a region of this protein,
between amino acids 511 and 624, is required for
PAP binding activity. The yeast two-hybrid system
supports these results by showing reduced growth
and a-galactosidase expression with truncation
in this region of eIFiso4G. PAP binds m
7GTP-
Sepharose and this interaction does not diminish
the binding of PAP to purified eIFiso4G, indicating
that a complex can form among the cap structure,
PAP and eIFiso4G. We incubated PAP with uncapped
and non-polyadenylated transcripts containing a
30 translation enhancer sequence (TE) known to
increase translation of the RNA in an eIF4F depen-
dent manner. We show that in the presence of
wheat germ lysate, PAP depurinates the uncapped
and non-polyadenylated transcripts containing a
functional wild-type 30TE, but does not depurinate
messages containing a non-functional mutant 30TE.
These results support our hypothesis that binding of
PAP to eIF4G and eIFiso4G can provide a mechanism
for PAP to access both uncapped and capped viral
RNAs for depurination.
INTRODUCTION
The eukaryotic translation initiation factor eIF4G is a large
cytosolic protein that serves as a scaffold for the binding and
interaction of several initiation factors and other proteins
that mediate the start of translation. eIF4G interacts with
the cap-binding protein, eIF4E, and increases its afﬁnity for
the m
7G structure at the 50end of the mRNA (1). Before the
40S ribosomal subunit contacts the mRNA, it is equipped with
the ternary complex of eIF2, GTP and Met-tRNAi. eIF3 binds
to this ribosomal subunit, and with the ternary complex, forms
the 43S initiation complex. eIF3 also binds to eIF4G, and
therefore, the 43S particle is brought to the 50 end of the
mRNA via interaction of initiation factors with eIF4G. The
factors eIF4A and 4B, also bound to eIF4G, function to
unwind RNA secondary structure and eIF1 and eIF1A enable
scanning to the AUG codon [reviewed in Refs (2–4)]. There-
fore, eIF4G is a central protein that mediates the connection
of factors to the mRNA and the preparation of the mRNA for
translation.
eIF4G can also serve as a central linking protein in cap-
independent translation, whereby the 43S particle accesses
the mRNA using an internal ribosome entry site [IRES,
reviewed in Refs (5–7)]. For example, several picornaviruses,
which rely on IRES-mediated translation of their RNAs, mod-
ify eIF4G to limit translation of capped cellular messages.
The 2A protease of rhinovirus and the Lb protease of foot-
and-mouth disease virus (FMDV) cleave eIF4G resulting in an
aminoterminalfragmentcontainingthe eIF4Ebindingsiteand
the C-terminal region containing interacting sites for eIF3 and
eIF4A (8,9). Hence, these viral proteins effectively uncouple
cap-binding from ribosome interaction. The C-terminal frag-
ment of eIF4G following proteolysis has been shown to dir-
ectlybinddomain 4oftheFMDVIRES,suggestingthateIF4G
acts as a linker to recruit translation factors and the ribosomal
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doi:10.1093/nar/gkj520small subunit in IRES-mediated initiation (10). The involve-
ment of eIF4G in both cap-dependent and cap-independent
initiation makes it a focus for proteins that regulate translation.
In this report, we describe a novel interaction between
eIFiso4G of wheat germ and pokeweed antiviral protein
(PAP), a ribosome inactivating protein synthesized by the
pokeweed plant (Phytolacca americana). Like all ribosome
inactivating proteins, PAP is an N-glycosidase that cleaves an
adenine from the conserved sarcin/ricin loop of the large
subunit ribosomal RNA (11,12). Depurinated ribosomes are
unable to bind elongation factor 2, resulting in inhibition
of translation and subsequent cell death [reviewed in Refs
(13,14)]. The antiviral activity of many ribosome inactivating
proteins has been attributed to their toxicity however, work
with mutants of PAP expressed in tobacco has shown that
antiviral activity can be separated from depurination of
ribosomes (15). Moreover, studies have demonstrated that
PAP depurinates viral RNAs such as Brome mosaic virus
(BMV) and Human immunodeﬁciency virus in vitro (16,17)
and limits virus multiplication in vivo without killing host
cells (18,19). We have previously shown that PAP is able
to bind the m
7G cap structure at the 50 end of some viral
messages and thus access them for depurination (16,20). How-
ever, this cap-dependent model does not explain the observed
inhibitory effect of PAP on the replication of uncapped
viruses such as inﬂuenza and poliovirus (21,22). We decided
to investigate whether PAP may also be able to interact with
translation initiation factors, and this work provides the ﬁrst
evidence that PAP binds to eIF4G and its isoform eIFiso4G.
In wheat, two forms of eIF4G exist, which differ in size,
180 (eIF4G) and 86 kDa (eIFiso4G), and they bear only
30% identity at the amino acid level (23,24). We show that
PAP binds speciﬁcally to each form, and by genetic and bio-
chemical analyses, we present evidence that a region of the
protein, between amino acids 511 and 624, is required for
PAP binding activity. It is not known how PAP targets
uncapped viral RNAs, however, its binding to either eIF4G
or eIFiso4G may provide a mechanism to access uncapped and
cappedtemplatesfordepurinationvia these central scaffolding
proteins.
MATERIALS AND METHODS
Expression and purification of initiation factors
The eIFiso4G gene of wheat and its truncation mutants
(N52, N90, N136, N186, C462, C489, C511, C624 and
C732) were cloned into pET-3d (Novagen) at the NcoI and
BamHI sites (25). Vectors were transformed into Escherichia
coli Rosetta(DE3)pLysS cells and induced with 0.5 mM IPTG
for 3 h. eIFiso4G and its truncation mutants were puriﬁed
from cell lysates with P-11 cellulose phosphate resin, essen-
tially as described (26). Puriﬁed proteins were concentrated
by ﬁltration centrifugation with a 10 kDa cut-off ﬁlter
(Amicon), washed twice with an equal volume of buffer
B-50 (20 mM HEPES–KOH, pH 7.6, 50 mM KCl, 1 mM
DTT, 0.1 mM EDTA) and reconcentrated, and stored at
 80 C.
The eIFiso4E gene of wheat was cloned into pET-3d
(Novagen) at the NcoI and BamHI sites (26). The vector
was transformed into E.coli BL21(DE3)pLysS cells and
induced with 0.5 mM IPTG for 1.5 h. eIFiso4E was puriﬁed
from cell-free extracts by incubation with m
7GTP-Sepharose
(Amersham Pharmacia) essentially as described (26). Puriﬁed
eIFiso4E was concentrated by ﬁltration centrifugation with a
10 kDa cut-off ﬁlter (Amicon), washed twice with an equal
volume of buffer V-50Ac (50 mM HEPES–KOH, pH 7.0,
50 mM KOAc, 10% glycerol, 1 mM DTT, 0.1 mM EDTA)
and reconcentrated, and stored at  80 C. Puriﬁed proteins
were visualized by separation in 12% SDS–PAGE and stain-
ing with Coomassie blue.
Far western assay
Puriﬁed proteins (50 nmol each) in blotting buffer (20 mM
HEPES–KOH, pH 7.6, 1 mM DTT, 0.1 mM EDTA, 0.1 mM
MgAc, 10% glycerol) were applied to nitrocellulose using
a dot-blot apparatus (Bio-Rad). The membrane was blocked
with 5% non-fat milk in blotting buffer for 2 h and then
incubated with 4 mg/ml puriﬁed PAP in the same buffer for
an additional 2 h. The membrane was probed with anti-PAP
monoclonal antibody (1:500) and PAP was visualized using
a chemiluminescence detection kit (NEN Life Science
Products).PuriﬁedPAP(12nmol)andribosomes ofSaccharo-
myces cerevisiae (10 nmol) were blotted as positive controls.
BSA (75nmol) andblotting bufferalone were used asnegative
controls.
Yeast two-hybrid analysis
The cDNA of eIFiso4E was cloned into the activating domain
plasmid pGAD-424 and cDNAs of eIFiso4G or its truncation
mutants were cloned into the binding domain plasmid pGBT-
9/N (25). The cDNA of PAPx was cloned into the activating
domain plasmid pAS2-1 (N. E. Tumer, Rutgers University).
PAPx is a point mutant of wild-type PAP [E176V, (27)]
and was used for transformation because it is not toxic to
yeast growth. Plasmids were transformed into the yeast strain
AH109 and plated onto SD -Leu, -Trp, -His, -Ade with 2%
dextrose and X-a-Gal (5-bromo-4-chloro-3-indolyl a-D-
galactopyranoside). Growth of colonies and presence of
blue colour owing to MEL1 (a-galactosidase) gene express-
ion were compared with cells transformed with cDNAs of
eIFiso4G and eIFiso4E. In addition, cells transformed with
either pTD1 and pVA3 or pTD1 and pLAM50 were used as
positive and negative controls for interaction, respectively
(Clontech Laboratories, Inc.).
Affinity pull-downs of PAP and eIFiso4G or truncation
mutants with m
7GTP-Sepharose
Equal molar amounts of PAP and eIFiso4G or its truncation
mutants (34 nmol) were mixed in 1 ml of buffer B-50 and
added to m
7GTP-Sepharose beads equilibrated in the same
buffer. Mixtures were rotated for 1 h at 4 C, and then
beads were pelleted at 15600· g for 2 min and washed
three times with buffer B-50. Proteins were eluted with
1m Mm
7GTP in buffer B-50, separated on 12% SDS–
PAGE and visualized with Coomassie blue staining.
To test for complex formation with m
7GTP-Sepharose in a
mixture of translation factors, 2 mg PAP was added to 500 mg
wheat germ lysate (Promega) depleted of eIF4E/eIFiso4E
and incubated with m
7GTP-Sepharose in 1 ml buffer B-50.
Mixtures were incubated and proteins eluted from the
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proteins. Eluted proteins were analyzed by immunoblot for
the presence of PAP or eIFiso4G, using polyclonal antibodies
directed against each PAP or eIFiso4G (1:5000). Lysate
(500 mg) was initially depleted of eIF4E/eIFiso4E by incuba-
tion with m
7GTP-Sepharose in 1 ml of buffer B-50 with rota-
tion for 1 h at 4 C. Beads were pelleted at 15600· g for 2 min
and discarded. The supernatant was incubated an additional
two times with m
7GTP-Sepharose. Recombinant eIFiso4G
(150 ng) was added to the ﬁnal supernatant prior to incubation
with PAP (2 mg) and additional m
7GTP-Sepharose.
DepurinationofuncappedRNAtemplateinthepresence
of wheat germ lysate
The plasmids pGLO18 and pGLO28 [previously referred to
as pLUC869 and pLUC869BF, respectively, (28)] encode
luciferase ﬂanked by the 50-untranslated region (50-UTR)
and 30-UTR of barley yellow dwarf virus (BYDV).
pGLO28 differs from pGLO18 in that it contains a four-
base duplication that ﬁlls the BamHI4837 site within the trans-
lational enhancer element of the viral 30-UTR. Plasmids were
linearized with SmaI and used as template for generation
of radiolabelled (a
32P-CTP, 3000 Ci/mmol, Amersham)
in vitro transcripts using T7 polymerase. Transcripts
(1.3 · 10
5 c.p.m.) were added to a wheat germ in vitro trans-
lation system (Promega) in the presence or absence of 5 ng
PAP in a total reaction volume of 25 ml. As a negative control
for the presence of lysate, the volume of lysate (12.5 ml) was
replaced by modiﬁed RIP buffer (60 mM KCl, 10 mM Tris–
HCl pH 7.4, 2.5 mM MgCl2). All samples were incubated
at 30 C for 30 min prior to extraction of total RNA. The
RNA was subsequently treated with aniline as described
previously (15). Samples were solubilized in formamide
buffer, separated on a 7 M urea/4.5% polyacrylamide gel,
dried against ﬁlter paper and visualized by autoradiography.
RESULTS
Expression and purification of translation initiation
factors
Recombinant eIF4G, eIFiso4G and terminally truncated
eIFios4G mutants used in this study were expressed and
puriﬁed from E.coli Rosetta(DE3)pLysS cells using phos-
phocellulose (P11) chromatography. eIFiso4E was puriﬁed
from BL21(DE3)pLysS cells using m
7GTP-Sepharose. Puri-
ﬁed proteins were separated by 12% SDS–PAGE and visual-
ized by Coomassie blue staining (Figure 1). PAP used in this
study was puriﬁed from pokeweed and was also included in
this gel. The major protein products are seen in each lane, with
few ‘background’ bands, indicating primarily intact and pure
preparations of full-length eIFiso4E, eIF4G, eIFiso4G and its
truncation derivatives.
In vitro binding of PAP to eIF4G, eIFiso4G and its
terminally truncated mutants
To determine if PAP bound directly to eIF4G or eIFiso4G
in vitro, far western analysis was conducted with puriﬁed
proteins applied directly to nitrocellulose using a dot-blot
apparatus. The nitrocellulose was incubated with puriﬁed
PAP and interactions between eIF4G or eIFiso4G and PAP
were detected by probing with a PAP-speciﬁc monoclonal
antibody. Importantly, the direct application of protein to
nitrocellulose allowed for the test of interactions without
denaturation of the proteins. The results in Figure 2A indicate
Figure 1. Separation of purified proteins. Recombinant eIFiso4E, eIF4G,
eIFiso4G and its truncation mutants (1 mg) were separated by 12% SDS–
PAGE and visualized with Coomassie blue stain. PAP (1 mg) was purified
frompokeweedleaves.Mreferstoproteinbroadrangemolecularmassmarker.
Figure 2. Far western analysis of PAP binding to eIFiso4G and its truncation
mutants. (A) Equal molar concentration of purified proteins (50 nmol) was
spotted onto nitrocellulose and incubated with purified PAP (4 mg/ml). PAP
binding to proteins was tested by probing with PAP monoclonal antibody
(1:500) and PAP was visualized by chemiluminescence. BSA (75 nmol) and
buffer alone were used as negative controls and purified yeast ribosomes
(10 nmol) were used as positive control for PAP binding. Purified PAP was
appliedasa positivecontrolforantibodyspecificity.(B) Schematicdrawingof
full-length eIFiso4G and its truncation mutants. The full-length eIFiso4G is
788 amino acids. Thick lines represent relativesizes of each mutant. Thinlines
indicate deleted regions from the full-length protein. The (+) sign denotes
bindingofthemutantformtoPAPand( )signdenotesnobinding,asdetected
by the far western method.
1176 Nucleic Acids Research, 2006, Vol. 34, No. 4that PAP binds directly to either eIF4G or eIFiso4G. As a
positive control, puriﬁed yeast ribosomes were blotted on
the nitrocellulose because we have previously shown that
PAP binds to ribosomal protein L3 (29). Negative controls
for binding were the application of BSA and buffer alone
to the nitrocellulose. Both the controls yielded validating
results.
To investigate the region of eIFiso4G involved in binding to
PAP, equal molar amounts of N- and C-terminal truncation
mutants of eIFiso4G were tested by the same method.
Figure 2A shows that PAP bound to the N-terminal truncation
mutants and to the C732 and C624 truncation mutants, but not
to the C-terminal mutants with larger deletions, namely C511,
C489 and C462. Improper folding of the eIFiso4G derivatives
was not likely, given that these truncation mutants were used
to characterize the binding site of eIFiso4E to eIFiso4G (25).
Our results, summarized in Figure 2B, suggest that PAP binds
to a central region of eIFiso4G and that the portion between
amino acids 511 and 624 is required for binding activity.
In vivo interaction between PAP and eIFiso4G
To test whether the in vitro interaction of PAP and eIFiso4G
could also be demonstrated in vivo, yeast two-hybrid vectors
encoding the full-length eIFiso4G or its truncation mutants
were expressed in the yeast strain AH109 with a vector encod-
ing the non-toxic mutant PAPx. Interaction on SD -Leu, -Trp,
-His, -Ade, 2% dextrose plates was assessed by growth and
a-galactosidase activity (intensity of blue colour) compared
with the positive control, cells transformed with plasmids
encoding the full-length eIFiso4G and the cap-binding protein
eIFiso4E. In addition, cells transformed with either pTD1
and pVA3 or pTD1 and pLAM50 were used as positive (+)
and negative ( ) controls for interaction, respectively. The
results indicate that PAP interacts with full-length eIFiso4G
and with all N-terminal truncation mutants and with the C732
and C624 mutants. However, little growth and a-galactosidase
activity could be detected in cells expressing both PAP and the
C-terminal truncation mutants C511, C489 and C462
(Figure 3A). These in vivo data correlate well with the
in vitro data (Figure 3B) and corroborate the importance of
the central region of eIFiso4G for PAP binding activity.
eIFiso4G-PAP-m
7G complex formation
PAP has been shown previously to bind m
7GTP-Sepharose
[Figure 4A (i)] and modeling studies suggest that binding
would occur at the enzymatic active site of PAP, similar to
the binding of adenine (16). Our present data indicate that
PAP can also bind to eIFiso4G [Figure 4A (ii)]. To determine
if PAP could simultaneously form a complex with both
eIFiso4G and the cap structure [Figure 4A (iii)], equal
molar amounts of PAP and eIFiso4G were incubated with
m
7GTP-Sepharose beads and eluted with 1 mM m
7GTP.
Eluted samples were separated by 12% SDS–PAGE and visu-
alized by Coomassie blue staining (Figure 4B). The presence
of both PAP and eIFiso4G in the eluted fraction indicates that
PAP was able to form a tertiary complex with full-length
eIFiso4G (Figure 4B, lane 10). Moreover, the data show
that the binding site of m
7GTP to PAP does not overlap the
bindingsiteofeIFiso4GtoPAP.Importantly,eIFiso4Gdidnot
bind in the absence of PAP (Figure 4B, lane 11), indicating
that PAP is responsible for ‘bridging’ the formation of the
eIFiso4G-PAP-cap complex. For the eIFiso4G mutants, all
except C462, C489 and C511 were able to form the trimeric
complex (Figure 4B, lanes 1–9). These results are consistent
with the PAP-binding properties deﬁned for eIFiso4G in vitro
and in vivo (Figures 2 and 3), respectively. Collectively, the
results indicate that PAP can simultaneously bind to both
eIFiso4G and m
7GTP to form a hetero-trimeric complex
[Figure 4A (iii)].
To determine if a similar complex could form using a mix-
ture of translation factors that would more closely mimic
in vivo conditions, PAP was added to wheat germ lysate
which was then incubated with m
7GTP-Sepharose beads. Fol-
lowing bead sedimentation, any bound proteins were eluted
with 1 mM m
7GTP and analyzed by immunoblot for the
presence of PAP or eIFiso4G. To exclude the possibility of
cap-4E-4G complex formation, lysate depleted of eIF4E and
Figure 3. (A) Yeast two-hybrid interactions between PAPx, eIFiso4G and its
truncation mutants. Activation domain plasmids encoding PAPx and binding
domain plasmids encoding full-length eIFiso4G or its truncation mutants were
transformed into the yeast strain AH109 and plated onto SD -Leu, -Trp, -His,
-Ade with 2% dextrose and X-a-Gal. Representative colonies were re-plated
onto the same medium to indicate relative growth and the presence of blue
colour. Cells transformed with cDNAs of full-length eIFiso4G and eIFiso4E
were plated as a positive control for interaction. In addition, cells transformed
with either pTD1 and pVA3 or pTD1 and pLAM50 were used as positive (+)
and negative ( ) controls for interaction, respectively. (B) Summary compar-
ison of in vivo and in vitro binding data for PAP and eIFiso4G mutants. In vivo
data were from results of panel A and in vitro data were from Figure 2.
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eIF4E and eIFiso4E depleted wheat germ lysate showed a
corresponding depletion of eIFiso4G (data not shown). There-
fore, recombinant eIFiso4G was added back to the lysate
depleted of wheat eIFiso4G, at a concentration that mimi-
cked endogenous levels (30). PAP addition to 4E-depleted/
4G-replenished wheat germ lysate and subsequent incubation
with m
7GTP-Sepharose indicated the presence of both PAP
and eIFiso4G in the eluate (Figure 4C). Therefore, PAP bound
to the cap structure and formed a complex between the cap
and eIFiso4G in wheat germ lysate.
Effect of a lysate component on the depurination
activity of PAP
We have shown previously that PAP is able to bind directly
to m
7GTP [Figure 5A (i)]. In addition, PAP could also indir-
ectly access capped mRNAs by binding to eIFiso4G. This
could occur by PAP binding to eIFiso4G that is associated
with eIFiso4E, which is bound to the cap, i.e. a PAP-eIFiso4G-
eIFiso4E-capped RNA complex [Figure 5A (ii)]. However,
this would be difﬁcult to demonstrate given the direct binding
of PAP to m
7GTP. Alternatively, eIFiso4G-dependent PAP
access to RNA could occur in a cap-independent manner.
BYDV is a positive-sense RNA virus that does not have a
cap or poly(A) tail. However, its efﬁcient translation is
stimulated by a 30 translation enhancer RNA sequence
(30TE) contained within its 30-UTR (31). Addition of excess
enhancer sequence inhibited translation of the uncapped RNA
in a wheat germ system, and inhibition was reversed by addi-
tion of elongation factor 4F, suggesting that the 30TE mediates
eIF4F-dependent translation (32). More recently, it has been
reported that the 30TE binds to eIF4F and eIFiso4F (33). We
suggest that PAP is able to access uncapped RNAs by bind-
ing to eIF4F and eIFiso4F (Figure 5B) and that transcripts
containing the 30-UTR and 30TE of BYDV would thus be
depurinated upon binding of PAP. To test this concept in a
translationally relevant context, which more closely mimics
the cellular environment, PAP activity was assessed using a
wheat germ lysate system. Following incubation of PAP in
wheat germ lysate with uncapped transcripts containing
a functional or non-functional 30TE, total RNA was recovered
and incubated with aniline as described previously (15).
Figure 6 illustrates that incubation of transcripts containing
the wild-type 30TE with PAP in the presence of lysate, and
subsequent treatment with aniline resulted in fragmentation
of the uncapped RNA. This fragmentation was not observed
with the same transcripts recovered from incubation lacking
lysate, indicating that a lysate component, presumably eIF4F
or eIFiso4F (33), enhanced depurination of the transcript by
PAP. In contrast, incubation of PAP in lysate with an mRNA
containing a defective 30TE, which is unable to mediate
Figure 5. Models illustrating how PAP may access RNA substrates. (A) In the
cap-dependent model, (i) PAP may access RNAs either through direct binding
of PAP to the cap structure or (ii) via complex formation between eIF4G/
eIFiso4G, eIF4E/eIFiso4E and cap. (B) In the cap-independent model, PAP
maybindtoeIF4G/eIFiso4G(a component ofeIF4F/eIFiso4F)andgainaccess
to uncapped, non-polyadenylated RNAs containing a 30TE associated with
eIF4F/eIFiso4F.
Figure 4. (A) Schematics of (i) PAP- m
7Gppp interaction shown previously;
(ii) PAP-eIFiso4G interaction shown in this study and (iii) potential trimeric
complex of eIFiso4G-PAP-m
7Gppp (investigated in B). (B) Complex forma-
tionofPAPandeIFiso4Gortruncationmutantswithm
7GTP-Sepharose.Equal
molar concentrations of PAP and eIFiso4G or its truncation mutants (34 nmol)
wereincubatedwithm
7GTP-Sepharose.Boundproteinswereelutedwith1mM
m
7GTP and separated by 12% SDS–PAGE. Eluted proteins were visualized
by Coomassie blue staining. Controls for binding to beads were PAP alone
and eIFiso4G alone. (C) Complex formation of PAP and eIFiso4G in wheat
germ lysate. Wheat germ lysate depleted of eIF4E and eIFiso4E and repleni-
shed with eIFiso4G was incubated with m
7GTP-Sepharose, with or without
the prior addition of PAP. Bound proteins were eluted with 1 mM m
7GTP and
analyzed by immunoblot for the presence of PAP or eIFiso4G using a poly-
clonal antibody (1:5000) to each protein.
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(Figure 6, lanes 7, 8). These results are consistent with the
concept that PAP gains access to the RNA by binding to
eIF4G/eIFiso4G in the eIF4F/eIFiso4F complex associated
with the 30TE.
DISCUSSION
In this report we show that PAP binds directly to eIF4G and
eIFiso4G. The yeast two-hybrid and far western analyses with
truncationmutants ofeIFiso4G indicatethat acentralregion of
the protein is required for binding to PAP. The binding site
of PAP on eIFiso4G was partially deﬁned in this work, show-
ing the portion between amino acids 511 and 624 as critical
for PAP binding activity. Comparison of the amino acid
sequence alignment between eIFiso4G and eIF4G indicates
that the region of eIFiso4G required for PAP binding activity
is conserved in both proteins (2). PAP has been shown pre-
viously to bind m
7GTP and we demonstrate here that PAP is
able to form a complex between the cap structure and eIFiso4-
G in wheat germ lysate. In addition, we show that PAP is able
to depurinate uncapped transcript in the presence of wheat
germ lysate. The transcript contained the 30TE sequence of
the UTR of BYDV, which has been shown previously to be
translated in an eIF4F dependent manner (32). Transcripts
containing a mutant form of the translation enhancer sequence
that are not affected by the presence of eIF4F were also not
depurinated by PAP, supporting the hypothesis that PAP
may access uncapped templates for depurination by binding
to eIF4G or eIFiso4G.
Complex formation among PAP, eIFiso4G and the cap
structure indicates that the binding sites for each do not over-
lap. Previous modeling studies showed that the active site of
PAP can accommodate the binding of m
7GDP similar to
the binding of an adenine (16). Therefore, it is unlikely that
eIFiso4G binds the active site of PAP. Testing the ability of
wild-type PAP to support translation in a lysate system
depleted of eIFiso4E and eIF4E was not attempted because
of the translation inhibition that would result from ribosome
depurination by PAP. Moreover, the non-depurinating active-
site mutant PAPx (27) does not efﬁciently bind m
7GTP
(unpublished data). However, PAPx was still able to bind
eIFiso4G in vivo, further suggesting that the interaction of
PAP with eIFiso4G is independent of its binding to cap.
Complex formation at the cap structure suggests that PAP
may compete with eIF4E or eIFiso4E for binding to the cap.
We have previously performed in vitro competition assays in
which m
7GTP-Sepharose was incubated with equal or increas-
ing molar concentrations of either PAP or eIFiso4E. Results
of this experiment indicated that PAP does not compete with
eIF4E or eIFiso4E for binding to cap analogue (unpublished
data). Recently, a novel cap-binding protein bearing sequence
homology to eIF4E and eIFiso4E was characterized from
Arabidopsis thaliana (34). Similar to PAP, this protein has
a higher afﬁnity for m
7GTP than other wheat cap-binding
proteins and also does not compete with eIF4E or eIFiso4E
for cap-binding (16,34). The role of the novel cap-binding
protein in vivo is not known, however, given that it does
not support the translation of all mRNAs, this protein may
sequester and prevent the translation of some messages. Even
though PAP bears no sequence homology to eIF4E or eIFiso4-
E, its binding to cap and eIF4G or eIFiso4G suggests that
it may interfere with or alter the translation of particular
messages.
Apart from enhancing the binding of eIF4E to
m
7GTP, eIF4G has been shown to bind directly to capped
and uncapped RNAs. For example, the central domain of
eIF4G has been cross-linked to a structural element of the
EMCV IRES upstream of the initiation codon and the pre-
sence of eIF4G stimulated the cross-linking of eIF4A to the
IRES (35). Moreover, yeast eIF4G contains an RNA recog-
nition motif characteristic of RNA-binding proteins (36) and
eIF4F exhibits RNA-binding activity independent of sequence
(37). Recently, a nucleic acid binding domain of wheat
eIFiso4G has been characterized to span amino acids 170–
201 and to bind both single and double-stranded sequences
(38). eIF4G of wheat germ has been shown to enhance the
IRES-mediated translation of naturally uncapped tobacco etch
virus RNA (39), and the central domain of mammalian
eIF4G can also support the translation of uncapped versions
of normally capped mRNAs (40,41). Therefore, several
reports illustrate how eIF4G or eIFiso4G is able to bind
mRNAs and viral RNAs, and is principally involved in trans-
lation of these messages, even without the participation of
the cap-binding protein eIF4E (42,43).
The mechanism by which PAP selects RNAs for depurina-
tion is not known. Figure 5 illustrates two models for PAP
access to capped or uncapped cellular and viral messages. The
ﬁrst model shows a cap-dependent mechanism whereby PAP
accesses RNAs by binding directly to the cap, independently
of eIF4F/eIFiso4F [Figure 5A (i)]. We have shown previously
that PAP binds the cap structure in vitro and speciﬁ-
cally depurinates capped BMV RNA transcripts as opposed
to uncapped BMV RNA templates (20). A single molecule of
PAP would not likely bind simultaneously to cap and an aden-
ine within the sequence of the RNA, given that both would
bind to the active site of PAP, rather, PAP would bind to cap
or the RNA. The binding of PAP to cap opens the possibility
that PAP competes with eIFiso4E for binding to the 50 end
of capped RNAs. Competition assays using increasing
Figure 6. Effect of wheat germ lysate on the depurination activity of PAP.
PAP (5 ng) was incubated with 3 · 10
5 c.p.m. of
32P-labelled transcript con-
taining either the wild-type (TE) or mutant (BFTE) 30-UTR of BYDV.
Transcripts were incubated in the presence or absence of wheat germ lysate
and subsequently treated with aniline. As a negative control, transcripts were
incubatedwithoutPAP.RNAswereseparatedon7Murea/4.5%acrylamidegel
and visualized by autoradiography.
Nucleic Acids Research, 2006, Vol. 34, No. 4 1179concentrations of either PAP or eIFiso4E were unable to show
increased binding of either protein to m
7GTP-Sepharose
(unpublished results). However, complex formation seen in
wheat germ lysate supports the simultaneous binding of
PAP to cap and eIFiso4G. An alternative cap-dependent mech-
anism is illustrated in Figure 5A (ii), whereby PAP accesses
RNAs by binding to eIF4F/eIFiso4F, which binds to cap. In
this scenario, PAP may also bind to cap via eIF4G/eIFiso4G,
independently of eIF4E/eIFiso4E. Primary dependence on
the presence of a cap does not completely explain PAP sub-
strate selection, given that PAP reduces the infectivity of
potato virus Y (44), which is uncapped, and the accumulation
of inﬂuenza virus and poliovirus, which are also uncapped
(21,22). Figure 5B illustrates a cap-independent mechanism,
whereby PAP may access uncapped templates via the associ-
ation of the RNA with translation initiation factors such as
eIF4F/eIFiso4F. For example, the 30TE of BYDV has been
shown to increase the level of translation in an eIF4F/eIFiso4F
dependent manner (32). In this study, we have shown that
PAP depurinates RNA containing the 30TE in the presence
of wheat germ lysate. However, no depurination was observed
of RNA containing a functionally deﬁcient 30TE that does not
associate with eIF4F/eIFiso4F. Given that the 30TE has been
reported to bind eIF4F and eIFiso4F (33), our results suggest
that the presence of eIF4F/eIFiso4F may allow the depurina-
tion of some uncapped RNAs. Therefore, binding of PAP to
eIF4G or eIFiso4G may provide PAP access to either capped
or uncapped templates.
The binding of PAP to eIF4G or eIFiso4G would position
PAP in close proximity to RNAs about to be translated. Many
viral proteins sequester eIF4G or eIFiso4G during infection
to ensure the preferential translation of viral messages as
opposed to cellular mRNAs. For example, both rotavirus
and inﬂuenza virus RNAs encode non-structural proteins
that bind to their respective viral RNAs and also to the
N-terminal region of eIF4G (45,46). Complex formation
between non-structural proteins and eIF4G speciﬁcally
favoursviralRNAtranslation,eitherbypreventingthebinding
of poly(A)-binding protein to eIF4G as with rotavirus, or by
selectively recruiting eIF4G to the 50 end of inﬂuenza virus
RNA. Therefore, the ability of PAP to bind eIF4G or eIFiso4G
suggests that during virus infection, PAP would have greater
access to viral RNAs than cellular mRNAs. The preferential
depurination of viral RNAs during infection is supported by
previous results of mammalian cell cultures incubated with
PAP, that cite a decline in virus titre without toxicity to the
host cells (19,22). In this report, we show that PAP binds
eIF4G and eIFiso4G, both in vivo and in vitro, and analyses
using truncation mutants indicate that a central portion of the
protein is required for this binding activity. Interaction of
PAP with eIF4G or eIFiso4G would place PAP in close prox-
imity to RNA substrates for depurination. Future studies will
focus on determining the extent to which this novel mechan-
ism for substrate selection contributes to the antiviral activity
of PAP in vivo.
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